• Je něco špatně v tomto záznamu ?

Transcatheter aortic valve durability, predictors of bioprosthetic valve dysfunction, longer-term outcomes - a review

AJ. Šolc, H. Línková, P. Toušek

. 2024 ; 21 (1-2) : 15-26. [pub] 20240204

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc24007772

INTRODUCTION: Transcatheter aortic valve implantation (TAVI) is one of the most significant inventions in cardiology, as it provides a viable minimally invasive treatment option for patients with aortic stenosis, the most common valvular disease in the developed world and one with a poor prognosis when left untreated. Using data available to date, this review aims to discuss and identify possible predictors of TAVI valve durability - an essential requirement for the device's wide-spread use, especially in younger patients. AREAS COVERED: This article explores the main causes of bioprosthetic valve dysfunction (BVD) based on pathophysiology and available data, and reviews possible predictors of BVD including prosthesis-related, procedure-related, and patient-related factors. An emphasis is made on affectable predictors, which could potentially be targeted with prevention management and improve valve durability. A literature search of online medical databases was conducted using relevant key words and dates; significant clinical trials were identified. A brief overview of important randomized controlled trials with mid to long-term follow-up is included in this article. EXPERT OPINION: Identifying modifiable predictors of valve dysfunction presents an opportunity to enhance and predict valve durability - a necessity as patients with longer life-expectancies are being considered for the procedure.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24007772
003      
CZ-PrNML
005      
20240423160239.0
007      
ta
008      
240412s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/17434440.2023.2288275 $2 doi
035    __
$a (PubMed)38032186
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Šolc, Abigail Johanna $u Third Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Cardiology, University Hospital Kralovské Vinohrady, Prague, Czech Republic $1 https://orcid.org/000900013069626X
245    10
$a Transcatheter aortic valve durability, predictors of bioprosthetic valve dysfunction, longer-term outcomes - a review / $c AJ. Šolc, H. Línková, P. Toušek
520    9_
$a INTRODUCTION: Transcatheter aortic valve implantation (TAVI) is one of the most significant inventions in cardiology, as it provides a viable minimally invasive treatment option for patients with aortic stenosis, the most common valvular disease in the developed world and one with a poor prognosis when left untreated. Using data available to date, this review aims to discuss and identify possible predictors of TAVI valve durability - an essential requirement for the device's wide-spread use, especially in younger patients. AREAS COVERED: This article explores the main causes of bioprosthetic valve dysfunction (BVD) based on pathophysiology and available data, and reviews possible predictors of BVD including prosthesis-related, procedure-related, and patient-related factors. An emphasis is made on affectable predictors, which could potentially be targeted with prevention management and improve valve durability. A literature search of online medical databases was conducted using relevant key words and dates; significant clinical trials were identified. A brief overview of important randomized controlled trials with mid to long-term follow-up is included in this article. EXPERT OPINION: Identifying modifiable predictors of valve dysfunction presents an opportunity to enhance and predict valve durability - a necessity as patients with longer life-expectancies are being considered for the procedure.
650    _2
$a lidé $7 D006801
650    _2
$a aortální chlopeň $x chirurgie $7 D001021
650    _2
$a selhání protézy $7 D011475
650    12
$a srdeční chlopně umělé $7 D006350
650    _2
$a výsledek terapie $7 D016896
650    12
$a transkatetrální implantace aortální chlopně $x škodlivé účinky $x metody $7 D065467
650    12
$a aortální stenóza $x chirurgie $7 D001024
650    12
$a bioprotézy $7 D001705
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Línková, Hana $u Third Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Cardiology, University Hospital Kralovské Vinohrady, Prague, Czech Republic
700    1_
$a Toušek, Petr $u Department of Cardiology, Third Faculty of Medicine, University Hospital Královské Vinohrady, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000225983635 $7 xx0105486
773    0_
$w MED00174420 $t Expert review of medical devices $x 1745-2422 $g Roč. 21, č. 1-2 (2024), s. 15-26
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38032186 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423160236 $b ABA008
999    __
$a ok $b bmc $g 2081637 $s 1217539
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 21 $c 1-2 $d 15-26 $e 20240204 $i 1745-2422 $m Expert review of medical devices $n Expert Rev Med Devices $x MED00174420
LZP    __
$a Pubmed-20240412

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...